Targeting the Paracaspase MALT1: A Potential Therapy to Overcome Ibrutinib Resistance in Relapsed/Refractory Mantle Cell Lymphoma Patients

被引：0
|
作者：
Jiang, Changying
Huang, Shengjian
Liu, Yang
Li, Carrie
Guo, Hui
Wang, Jeffrey
Lopez, Elyse
Zhang, Hui
Lorence, Elizabeth A.
Merolle, Maria
Balaji, Swathi
Ahmed, Makhdum
Nomie, Krystle
Lin, Xin
Zhang, Liang
Wang, Michael
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
574
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory (R/R) mantle cell lymphoma (MCL).
    Epperla, Narendranath
    Hamadani, Mehdi
    Ahn, Kwang Woo
    Oak, Eunhye
    Cashen, Amanda F.
    Kanate, Abraham Sebastian
    Calzada, Oscar
    Farmer, Zachary Luke
    Tallarico, Michael
    Nabhan, Chadi
    Costa, Luciano J.
    Kenkre, Vaishalee Padgaonkar
    Ghosh, Nilanjan
    Cohen, Jonathon Brett
    Hari, Parameswaran
    Fenske, Timothy S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [22] BTK and MALT1 are critical for cell adhesion and dissemination in mantle cell lymphoma
    Jiang, Vivian Changying
    Liu, Yang
    Cai, Qingsong
    McIntosh, Joseph M.
    Li, Yijing
    Chen, Zhihong
    Lee, Heng-Huan
    Wang, Wei
    Yao, Yixin
    Nie, Lei
    Wang, Michael
    CANCER RESEARCH, 2023, 83 (07)
  • [23] Targeting PI3K and PLK1 to Overcome Ibrutinib-Venetoclax Resistance in Mantle Cell Lymphoma
    Jiang, Changying
    Zhang, Rongjia
    Zhang, Shaojun
    Lee, William
    Huang, Shengjian
    Liu, Yang
    Leeming, Angela
    McIntosh, Joseph Mitchell
    Jain, Preetesh
    Nomie, Krystle
    Wang, Linghua
    Wang, Michael L.
    BLOOD, 2019, 134
  • [24] The Development of a Precision Medicine Platform to Overcome Ibrutinib Resistance in Mantle Cell Lymphoma
    Liu, Yang
    Zhao, Shuangtao
    Jiang, Changying
    Yao, Yixin
    Murfin, Kelley Paige
    Grundman, Hadley
    Zhang, Liang
    Nomie, Krystle
    Wang, Linghua
    Wang, Michael
    BLOOD, 2019, 134
  • [25] Developing Novel Therapeutic Strategies to Overcome Ibrutinib Resistance in Mantle Cell Lymphoma
    Lan Pham
    Zhang, Liang
    Tao, Wenjing
    Zhao, Donglu
    Zhang, Hui
    Xie, Jingmeng
    Wang, Jack
    Nomie, Krystle
    Wang, Michael
    BLOOD, 2015, 126 (23)
  • [26] Genetically Defined Metabolic Targets Overcome Ibrutinib Resistance in Mantle Cell Lymphoma
    Zhang, Liang
    Guo, Hui
    Zhang, Hui
    Yao, Yixin
    Liu, Yang
    Zhang, Shaojun
    Rui, Lixin
    Wang, Linghua
    Nomie, Krystle
    Wang, Michael L.
    BLOOD, 2019, 134
  • [27] Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma
    Goto, Hideki
    Ito, Satoshi
    Kizaki, Masahiro
    Yamaguchi, Masaki
    Fukuhara, Noriko
    Kato, Koji
    Saito, Toko
    Terui, Yasuhito
    Okubo, Sumiko
    Soshin, Tomomi
    Zeng, Jiewei
    Honda, Hideyuki
    Badawi, Mohamed
    Ross, Jeremy A.
    Izutsu, Koji
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (02) : 232 - 240
  • [28] Clinical outcomes of ibrutinib in patients with relapsed or refractory mantle cell lymphoma: Korean multicenter, retrospective analysis
    Yi, J. H.
    Kim, W. S.
    Kim, S. J.
    Yoon, D. H.
    Suh, C.
    Chang, M. H.
    Yang, D. H.
    Jo, J-C.
    Hyun, S. Y.
    Eom, H-S.
    Lee, J-O.
    Kwon, J. H.
    Han, S. H.
    Lee, S-S.
    Kwak, J-Y.
    Kim, S. H.
    ANNALS OF ONCOLOGY, 2019, 30
  • [29] Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma
    Izutsu, Koji
    Goto, Hideki
    Kizaki, Masahiro
    Yamaguchi, Masaki
    Fukuhara, Noriko
    Kato, Koji
    Saito, Toko
    Terui, Yasuhito
    Okubo, Sumiko
    Soshin, Tomomi
    Mukherjee, Nabanita
    Honda, Hideyuki
    Badawi, Mohamed
    Ross, Jeremy
    Ishizawa, Kenichi
    ANNALS OF ONCOLOGY, 2023, 34 : S1428 - S1428
  • [30] Real-World Outcomes for Patients Treated with Ibrutinib for Relapsed/Refractory Mantle Cell Lymphoma in Denmark
    Trab, Trine
    Chanchiri, Iman
    Al-Mashhadi, Ahmed
    Berggreen, Emma
    Rasch, Stine
    Johansen, Mette
    Husby, Simon
    Clausen, Michael Roost
    Larsen, Thomas Stauffer
    Desseau-Arp, Andriette C.
    Christensen, Jacob Haaber
    Pedersen, Robert Schou
    Frederiksen, Mikael
    Brown, Peter de Nully
    El-Galaly, Tarec Christoffer
    Gronbaek, Kirsten
    BLOOD, 2024, 144 : 6325 - 6326
12345